SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...
Using cytometry by time of flight (CyTOF) technology, researchers measure multiple parameters for comprehensive cell phenotyping and functional analyses. This capability is especially important when ...
Cancer is marked by remarkable cellular heterogeneity: malignant clones coexist with diverse immune, stromal and vascular elements that continually evolve under therapeutic pressure (1–3).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback